This compound is a pharmaceutical intermediate cataloged for use in research related to the hepatitis C virus (HCV). It is a small-molecule reagent with structural features including multiple ring systems and polar functional groups, commonly supplied for laboratory-scale synthesis studies.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1998705-62-6
(S)-1-N-Boc-piperidine-2-ethanol
pharmaceutical intermediate
4-Methylbenzene-1-sulfonic acid--(2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine (1/1)
pharmaceutical intermediate
5-(4-Bromophenyl)-2-furaldehyde
Pharmaceutical intermediate for synthesis
N5-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-L-ornithine
protected arginine derivative for peptide synthesis
(2R,3R,4R,5R)-5-[2-amino-6-(methylamino)purin-9-yl]-4-fluoro-2-(hydroxymethyl)-4-methyloxolan-3-ol
HPINXBYYNVDDEB-GSWPYSDESA-N
C[C@]1([C@@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)N)NC)CO)O)F